Company: MDCXW
Filing Date: 2025-03-07
Form Type: 253G1
Source: 0001062993-25-004966
Chunk: 235

Company: Medicus Pharma Ltd.
Filing Date: 2025-03-07
Form: 253G1
Chunk 235
---
 |          $ |   |     |           $ |   |
| Balance - December 31, 2022     |     |   7,196,069 |   |     |  6,854,222 |   |     |  1,893,065 |   |     |  3,221,095 |   |     |  10,075,317 |   |
| Dividend accrual and conversion |     |           - |   |     |    281,586 |   |     |          - |   |     |    150,000 |   |     |     431,586 |   |
| Conversion of accrued dividends |     |   3,742,741 |   |     |          - |   |     |    659,299 |   |     |          - |   |     |           - |   |
| Redemption                      |     | (10,938,810 | ) |     | (7,135,808 | ) |     | (2,552,364 | ) |     | (3,371,095 | ) |     | (10,506,903 | ) |
| Balance - December 31, 2023     |     |           - |   |     |          - |   |     |          - |   |     |          - |   |     |           - |   |

8. Share capital

[a] Authorized

The Company has authorized unlimited common shares with no par value. Each holder of common shares is entitled to one vote for each share owned on all matters voted upon by shareholders.

[b] Issued and outstanding

|                                                           |     | Common shares |     |            |
|:----------------------------------------------------------|:----|--------------:|:----|-----------:|
|                                                           |     |             # |     |          $ |
| Balance - December 31, 2022(i)                            |     |     1,884,900 |     |    194,538 |
| Acquisition of Interactive Capital Partners Ltd. (note 4) |     |       287,471 |     |  1,149,882 |
| Conversion of preferred shares(ii)                        |     |     3,952,366 |     | 10,506,903 |
| Conversion of promissory notes(ii)                        |     |       647,224 |     |  2,724,566 |
| Conversion of note payable(ii)